In alignment with previous findings, our study discerned a noteworthy escalation in MDA content and a great decrease in the contents of SOD and GPX in the hepatic tissue of NAFLD mice. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.